Functional expression of inwardly rectifying and ATP‐sensitive potassium channels in human pulmonary artery smooth muscle and endothelial cells

B. Barreira,D. Morales-Cano,L. Moreno,B. de Olaiz,Rui Adão,Á. Cogolludo,F. Perez-Vizcaino,María Sancho

Published 2026 in Journal of Physiology

ABSTRACT

The resting membrane potential (VM) of vascular cells is a key determinant of arterial tone, integrating multiple ionic conductances to control smooth muscle contractility and endothelial signalling. In the human pulmonary circulation, the specific K+ channels responsible for setting the VM of smooth muscle cells (SMCs) and endothelial cells (ECs) remain incompletely defined. This study investigated whether inwardly rectifying (Kir2) and ATP‐sensitive (KATP) K+ channels are functionally expressed in native human pulmonary artery (PA) SMCs and ECs and assessed their contribution to vascular tone. Combining patch‐clamp electrophysiology, immunofluorescence and wire myography, we evaluated channel expression and function in freshly isolated PASMCs and PAECs, and intact PAs. Kir2 channels were identified by Ba2+‐sensitive inward currents with a characteristic rectification profile, supported by immunolabelling of Kir2.1 and Kir2.2 subunits. Functionally, BaCl2 induced concentration‐dependent contractions of PA rings and significantly attenuated acetylcholine‐evoked, endothelium‐dependent relaxation, revealing a tonic vasodilatory role for Kir2 channels. KATP currents, activated by pinacidil and blocked by glibenclamide and PNU‐37883A, were also observed in PASMCs and PAECs, consistent with immunodetection of Kir6.1 and SUR2 subunits. In isolated PAs, pinacidil elicited concentration‐dependent vasodilatation, which was significantly reduced by KATP channel blockade. Collectively, these findings demonstrate for the first time the functional presence of Kir2 and KATP channels in native human pulmonary vascular cells, and their modulatory role on VM and arterial tone. These channels emerge as key electro‐metabolic regulators of pulmonary vascular function and promising therapeutic targets in diseases characterized by VM dysregulation, such as pulmonary arterial hypertension.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-55 of 55 references · Page 1 of 1

CITED BY

  • No citing papers are available for this paper.

Showing 0-0 of 0 citing papers · Page 1 of 1